{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:28:49Z","timestamp":1770834529907,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41390-019-0499-0","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:02:37Z","timestamp":1562630557000},"page":"603-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fetuin-A deficiency is associated with infantile cortical hyperostosis (Caffey disease)"],"prefix":"10.1038","volume":"86","author":[{"given":"Rona","family":"Merdler-Rabinowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Somekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atar","family":"Lev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salama","family":"Ihsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adib","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raz","family":"Somech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos J.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"499_CR1","first-page":"347","volume":"50","author":"J Caffey","year":"1957","unstructured":"Caffey, J. Infantile cortical hyperostosis; a review of the clinical and radiographic features. Proc. R. Soc. Med. 50, 347\u2013354 (1957).","journal-title":"Proc. R. Soc. Med."},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0022-3476(82)80153-4","volume":"101","author":"E Heyman","year":"1982","unstructured":"Heyman, E., Laver, J. & Beer, S. Prostaglandin synthetase inhibitor in Caffey disease. J. Pedia. 101, 314 (1982).","journal-title":"J. Pedia."},{"key":"499_CR3","first-page":"55","volume":"136","author":"RA Saul","year":"1982","unstructured":"Saul, R. A., Lee, W. H. & Stevenson, R. E. Caffey\u2019s disease revisited. Further evidence for autosomal dominant inheritance with incomplete penetrance. Am. J. Dis. Child. 136, 55\u201360 (1982).","journal-title":"Am. J. Dis. Child."},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1172\/JCI22760","volume":"115","author":"RC Gensure","year":"2005","unstructured":"Gensure, R. C. et al. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J. Clin. Invest. 115, 1250\u20131257 (2005).","journal-title":"J. Clin. Invest."},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI25148","volume":"115","author":"FH Glorieux","year":"2005","unstructured":"Glorieux, F. H. Caffey disease: an unlikely collagenopathy. J. Clin. Invest. 115, 1142\u20131144 (2005).","journal-title":"J. Clin. Invest."},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10038-008-0328-5","volume":"53","author":"TJ Cho","year":"2008","unstructured":"Cho, T. J. et al. The c.3040C>T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease). J. Hum. Genet. 53, 947\u2013949 (2008).","journal-title":"J. Hum. Genet."},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s12098-010-0339-z","volume":"78","author":"P Ranganath","year":"2011","unstructured":"Ranganath, P., Laine, C. M., Gupta, D., Makitie, O. & Phadke, S. R. COL1A1 mutation in an Indian child with Caffey disease. Indian J. Pediatr. 78, 877\u2013879 (2011).","journal-title":"Indian J. Pediatr."},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00431-011-1463-0","volume":"170","author":"P Cerruti-Mainardi","year":"2011","unstructured":"Cerruti-Mainardi, P. et al. Infantile cortical hyperostosis and COL1A1 mutation in four generations. Eur. J. Pediatr. 170, 1385\u20131390 (2011).","journal-title":"Eur. J. Pediatr."},{"key":"499_CR9","doi-asserted-by":"crossref","first-page":"bcr2012006996","DOI":"10.1136\/bcr-2012-006996","volume":"2012","author":"AR Prior","year":"2012","unstructured":"Prior, A. R., Moldovan, O., Azevedo, A. & Moniz, C. Caffey disease in neonatal period: the importance of the family! BMJ Case Rep. 2012, bcr2012006996 (2012).","journal-title":"BMJ Case Rep."},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.7196\/SAMJ.2016.v106i6.11007","volume":"106","author":"JW Spranger","year":"2016","unstructured":"Spranger, J. W. & Lausch, E. Hyperostosis in siblings. S Afr. Med. J. 106, S98\u2013S99 (2016).","journal-title":"S Afr. Med. J."},{"key":"499_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00431-013-2252-8","volume":"173","author":"T Kitaoka","year":"2014","unstructured":"Kitaoka, T. et al. Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literature. Eur. J. Pediatr. 173, 799\u2013804 (2014).","journal-title":"Eur. J. Pediatr."},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/ajmg.a.32351","volume":"146A","author":"A Kamoun-Goldrat","year":"2008","unstructured":"Kamoun-Goldrat, A. et al. Prenatal cortical hyperostosis with COL1A1 gene mutation. Am. J. Med. Genet. A 146A, 1820\u20131824 (2008).","journal-title":"Am. J. Med. Genet. A"},{"key":"499_CR13","doi-asserted-by":"publisher","first-page":"441e441","DOI":"10.1016\/j.jpeds.2007.02.066","volume":"151","author":"K Estes","year":"2007","unstructured":"Estes, K., Nowicki, M. & Bishop, P. Cortical hyperostosis secondary to prostaglandin E1 therapy. J. Pediatr. 151, 441e441 (2007). 441.","journal-title":"J. Pediatr."},{"key":"499_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1542\/peds.93.3.417","volume":"93","author":"K Woo","year":"1994","unstructured":"Woo, K., Emery, J. & Peabody, J. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation. Pediatrics 93, 417\u2013420 (1994).","journal-title":"Pediatrics"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/NEJM195402252500802","volume":"250","author":"JB Sidbury Jr.","year":"1954","unstructured":"Sidbury, J. B. Jr. & Sidbury, J. B. Infantile cortical hyperostosis; an inquiry into the etiology and pathogenesis. N. Engl. J. Med. 250, 309\u2013314 (1954).","journal-title":"N. Engl. J. Med."},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-3476(53)80207-6","volume":"42","author":"WP Barba","year":"1953","unstructured":"Barba, W. P. & Freriks, D. J. The familial occurrence of infantile cortical hyperostosis in utero. J. Pediatr. 42, 141\u2013150 (1953).","journal-title":"J. Pediatr."},{"key":"499_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ajmg.a.20062","volume":"120A","author":"S Schweiger","year":"2003","unstructured":"Schweiger, S. et al. Antenatal onset of cortical hyperostosis (Caffey disease): case report and review. Am. J. Med. Genet. A 120A, 547\u2013552 (2003).","journal-title":"Am. J. Med. Genet. A"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00439-005-1286-z","volume":"117","author":"C Lavebratt","year":"2005","unstructured":"Lavebratt, C., Wahlqvist, S., Nordfors, L., Hoffstedt, J. & Arner, P. AHSG gene variant is associated with leanness among Swedish men. Hum. Genet. 117, 54\u201360 (2005).","journal-title":"Hum. Genet."},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00439-016-1756-5","volume":"136","author":"M Reza Sailani","year":"2017","unstructured":"Reza Sailani, M. et al. Association of AHSG with alopecia and mental retardation (APMR) syndrome. Hum. Genet. 136, 287\u2013296 (2017).","journal-title":"Hum. Genet."},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00042737-200204000-00009","volume":"14","author":"L Kalabay","year":"2002","unstructured":"Kalabay, L. et al. Human fetuin\/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. Eur. J. Gastroenterol. Hepatol. 14, 389\u2013394 (2002).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"499_CR21","doi-asserted-by":"publisher","first-page":"e23730","DOI":"10.1371\/journal.pone.0023730","volume":"6","author":"X Zhu","year":"2011","unstructured":"Zhu, X. et al. Genetic variation of the human alpha-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection. PLoS ONE 6, e23730 (2011).","journal-title":"PLoS ONE"},{"key":"499_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5507\/bp.2015.018","volume":"159","author":"AM Dabrowska","year":"2015","unstructured":"Dabrowska, A. M., Tarach, J. S., Wojtysiak-Duma, B. & Duma, D. Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub. 159, 352\u2013359 (2015).","journal-title":"Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub."},{"key":"499_CR23","doi-asserted-by":"publisher","first-page":"e2450","DOI":"10.7717\/peerj.2450","volume":"4","author":"MI Abdullah","year":"2016","unstructured":"Abdullah, M. I., Lee, C. C., Mat Junit, S., Ng, K. L. & Hashim, O. H. Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins. PeerJ 4, e2450 (2016).","journal-title":"PeerJ"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12014-018-9194-0","volume":"15","author":"F Shi","year":"2018","unstructured":"Shi, F. et al. Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer. Clin. Proteomics 15, 18 (2018).","journal-title":"Clin. Proteomics"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/CIRCRESAHA.110.234260","volume":"108","author":"W Jahnen-Dechent","year":"2011","unstructured":"Jahnen-Dechent, W., Heiss, A., Schafer, C. & Ketteler, M. Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 108, 1494\u20131509 (2011).","journal-title":"Circ. Res."},{"key":"499_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/256430a0","volume":"256","author":"IR Dickson","year":"1975","unstructured":"Dickson, I. R., Poole, A. R. & Veis, A. Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature 256, 430\u2013432 (1975).","journal-title":"Nature"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bone.2015.10.008","volume":"83","author":"D Mattinzoli","year":"2016","unstructured":"Mattinzoli, D. et al. FGF23-regulated production of Fetuin-A (AHSG) in osteocytes. Bone 83, 35\u201347 (2016).","journal-title":"Bone"},{"key":"499_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00109-007-0294-y","volume":"86","author":"W Jahnen-Dechent","year":"2008","unstructured":"Jahnen-Dechent, W., Schafer, C., Ketteler, M. & McKee, M. D. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J. Mol. Med. (Berl.) 86, 379\u2013389 (2008).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"12755","DOI":"10.1074\/jbc.271.22.12755","volume":"271","author":"M Demetriou","year":"1996","unstructured":"Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C. & Dennis, J. W. Fetuin\/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J. Biol. Chem. 271, 12755\u201312761 (1996).","journal-title":"J. Biol. Chem."},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"28514","DOI":"10.1074\/jbc.274.40.28514","volume":"274","author":"C Binkert","year":"1999","unstructured":"Binkert, C. et al. Regulation of osteogenesis by fetuin. J. Biol. Chem. 274, 28514\u201328520 (1999).","journal-title":"J. Biol. Chem."},{"key":"499_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI17202","volume":"112","author":"C Schafer","year":"2003","unstructured":"Schafer, C. et al. The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112, 357\u2013366 (2003).","journal-title":"J. Clin. Invest."},{"key":"499_CR32","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/ndt\/gfm094","volume":"22","author":"R Westenfeld","year":"2007","unstructured":"Westenfeld, R. et al. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol. Dial. Transpl. 22, 1537\u20131546 (2007).","journal-title":"Nephrol. Dial. Transpl."},{"key":"499_CR33","doi-asserted-by":"publisher","first-page":"e47338","DOI":"10.1371\/journal.pone.0047338","volume":"7","author":"J Seto","year":"2012","unstructured":"Seto, J. et al. Accelerated growth plate mineralization and foreshortened proximal limb bones in fetuin-A knockout mice. PLoS ONE 7, e47338 (2012).","journal-title":"PLoS ONE"},{"key":"499_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.orthres.2004.11.010","volume":"23","author":"B Rittenberg","year":"2005","unstructured":"Rittenberg, B. et al. Regulation of BMP-induced ectopic bone formation by Ahsg. J. Orthop. Res. 23, 653\u2013662 (2005).","journal-title":"J. Orthop. Res."},{"key":"499_CR35","doi-asserted-by":"publisher","first-page":"19991","DOI":"10.1074\/jbc.M112234200","volume":"277","author":"M Szweras","year":"2002","unstructured":"Szweras, M. et al. alpha 2-HS glycoprotein\/fetuin, a transforming growth factor-beta\/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J. Biol. Chem. 277, 19991\u201319997 (2002).","journal-title":"J. Biol. Chem."},{"key":"499_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF02405000","volume":"35","author":"IR Dickson","year":"1983","unstructured":"Dickson, I. R., Bagga, M. & Paterson, C. R. Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta. Calcif. Tissue Int. 35, 16\u201320 (1983).","journal-title":"Calcif. Tissue Int."},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1042\/cs0580435","volume":"58","author":"BA Ashton","year":"1980","unstructured":"Ashton, B. A. & Smith, R. Plasma alpha 2HS-glycoprotein concentration in Paget\u2019s disease of bone: its possible significance. Clin. Sci. (Lond.) 58, 435\u2013438 (1980).","journal-title":"Clin. Sci. (Lond.)"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1373\/clinchem.2005.059253","volume":"52","author":"D Hendig","year":"2006","unstructured":"Hendig, D. et al. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin. Chem. 52, 227\u2013234 (2006).","journal-title":"Clin. Chem."},{"key":"499_CR39","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/jid.2009.423","volume":"130","author":"Q Jiang","year":"2010","unstructured":"Jiang, Q., Dibra, F., Lee, M. D., Oldenburg, R. & Uitto, J. Overexpression of fetuin-a counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (abcc6(-\/-)). J. Invest. Dermatol. 130, 1288\u20131296 (2010).","journal-title":"J. Invest. Dermatol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0499-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:24:08Z","timestamp":1744151048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0499-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0499-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}